FAMOTIDINE
NDC 43602-602, Famotidine, tablet, from Ascent Pharmaceuticals, Inc..
- Product NDC
- 43602-602
- Status
- Listed
- Labeler
- Ascent Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA216030
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43602-602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE20 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43602-602-03 | 43602060203 | 1 BOTTLE in 1 CARTON (43602-602-03) / 300 TABLET in 1 BOTTLE |
| 43602-602-30 | 43602060230 | 1 BOTTLE in 1 CARTON (43602-602-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43602-602 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43602-602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43602-602. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.